- About this Journal ·
- Abstracting and Indexing ·
- Advance Access ·
- Aims and Scope ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
Infectious Diseases in Obstetrics and Gynecology
Volume 2010 (2010), Article ID 326369, 7 pages
Evidence for Vertical Transmission of HPV from Mothers to Infants
1Department of Epidemiology, College of Public Health, University of Iowa, Iowa City, IA 52242, USA
2Department of Obstetrics/Gynecology, College of Medicine, University of Iowa, Iowa City, IA 52242, USA
3Veterans Affairs Medical Center, Iowa City, IA 52240, USA
4Department of Experimental Virology, Institute of Hematology and Blood Transfusion, U nemocnice 1, 128 20 Prague 2, Czech Republic
Received 26 June 2009; Revised 2 November 2009; Accepted 10 February 2010
Academic Editor: Kevin Ault
Copyright © 2010 Elaine M. Smith et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- W. Cates Jr., “Estimates of the incidence and prevalence of sexually transmitted diseases in the United States,” Sexually Transmitted Diseases, vol. 26, no. 4, pp. S2–S7, 1999.
- L. Koutsky, “Epidemiology of genital human papillomavirus infection,” American Journal of Medicine, vol. 102, no. 5A, pp. 3–8, 1997.
- N. Jay and A.-B. Moscicki, “Human papillomavirus infections in women with HIV disease: prevalence, risk, and management,” AIDS Reader, vol. 10, no. 11, pp. 659–668, 2000.
- S. K. Kjaer, B. Chackerian, A. J. C. van den Brule, et al., “High-risk human papillomavirus is sexually transmitted: evidence from a follow-up study of virgins starting sexual activity (Intercourse),” Cancer Epidemiology Biomarkers and Prevention, vol. 10, no. 2, pp. 101–106, 2001.
- M. H. Puranen, M. H. Yliskoski, S. V. Saarikoski, K. J. Syrjanen, and S. M. Syrjanen, “Exposure of an infant to cervical human papillomavirus infection of the mother is common,” American Journal of Obstetrics and Gynecology, vol. 176, no. 5, pp. 1039–1045, 1997.
- D. H. Watts, L. A. Koutsky, K. K. Holmes, et al., “Low risk of perinatal transmission of human papillomavirus: results from a prospective cohort study,” American Journal of Obstetrics and Gynecology, vol. 178, no. 2, pp. 365–373, 1998.
- M. Puranen, M. Yliskoski, S. Saarikoski, K. Syrjanen, and S. Syrjanen, “Vertical transmission of human papillomavirus from infected mothers to their newborn babies and persistence of the virus in childhood,” American Journal of Obstetrics and Gynecology, vol. 174, no. 2, pp. 694–699, 1996.
- B. D. Fredericks, A. Balkin, H. W. Daniel, J. Schonrock, B. Ward, and I. H. Frazer, “Transmission of human papillomavirus from mother to child,” Australian and New Zealand Journal of Obstetrics and Gynecology, vol. 33, pp. 30–32, 1993.
- E. M. Smith, S. R. Johnson, D. Jiang, et al., “The association between pregnancy and human papilloma virus prevalence,” Cancer Detection and Prevention, vol. 15, no. 5, pp. 397–402, 1991.
- E. M. Smith, J. M. Ritchie, J. Yankowitz, et al., “Human papillomavirus prevalence and types in newborns and parents: concordance and modes of transmission,” Sexually Transmitted Diseases, vol. 31, no. 1, pp. 57–62, 2004.
- E. M. Smith, S. R. Johnson, T. Cripe, et al., “Perinatal transmission and maternal risks of human papillomavirus infection,” Cancer Detection and Prevention, vol. 19, no. 2, pp. 196–205, 1995.
- C.-J. Tseng, C.-C. Liang, Y.-K. Soong, and C.-C. Pao, “Perinatal transmission of human papillomavirus in infants: relationship between infection rate and mode of delivery,” Obstetrics and Gynecology, vol. 91, no. 1, pp. 92–96, 1998.
- P. Tenti, R. Zappatore, P. Migliora, A. Spinillo, C. Belloni, and L. Carnevali, “Perinatal transmission of human papillomavirus from gravidas with latent infections,” Obstetrics and Gynecology, vol. 93, no. 4, pp. 475–479, 1999.
- M. A. M. Rintala, S. E. Grénman, M. H. Puranen, et al., “Transmission of high-risk human papillomavirus (HPV) between parents and infant: a prospective study of HPV in families in Finland,” Journal of Clinical Microbiology, vol. 43, no. 1, pp. 376–381, 2005.
- J. Cason, J. N. Kaye, R. J. Jewers, et al., “Perinatal infection and persistence of human papillomavirus types 16 and 18 in infants,” Journal of Medical Virology, vol. 47, no. 3, pp. 209–218, 1995.
- J. N. Kaye, W. G. Starkey, B. Kell, et al., “Human papillomavirus type 16 in infants: use of DNA sequence analyses to determine the source of infection,” Journal of General Virology, vol. 77, no. 6, pp. 1139–1143, 1996.
- E. M. Smith, J. M. Ritchie, M. Pawlita, et al., “Human papillomavirus seropositivity and risks of head and neck cancer,” International Journal of Cancer, vol. 120, no. 4, pp. 825–832, 2007.
- E. Hamšíková, M. Šmahel, M. Sapp, et al., “Correlation between the presence of anti HPV33 VLP antibodies and HPV DNA in cervical neoplasia patients,” Archives of Virology, vol. 142, no. 2, pp. 413–416, 1997.
- R. Tachezy, E. Hamšíková, T. Hájek, et al., “Human papillomavirus genotype spectrum in Czech women: correlation of HPV DNA presence with antibodies against HPV-16, 18, and 33 virus-like particles,” Journal of Medical Virology, vol. 58, no. 4, pp. 378–386, 1999.
- R. Tachezy, I. Mikyšková, V. Ludvíková, et al., “Longitudinal study of patients after surgical treatment for cervical lesions: detection of HPV DNA and prevalence of HPV-specific antibodies,” European Journal of Clinical Microbiology and Infectious Diseases, vol. 25, no. 8, pp. 492–500, 2006.
- R. Tachezy, T. Jirasek, M. Salakova, et al., “Human papillomavirus infection and tumours of the anal canal: correlation of histology, PCR detection in paraffin sections and serology,” APMIS, vol. 115, no. 3, pp. 195–203, 2007.
- E. Hamšíková, V. Ludvikova, R. Tachezy, J. Kovarik, L. Brouskova, and V. Vonka, “Longitudinal follow-up of antibody response to selected antigens of human papillomaviruses and herpesviruses in patients with invasive cervical carcinoma,” International Journal of Cancer, vol. 86, no. 3, pp. 351–355, 2000.
- E. M. Smith, J. M. Ritchie, K. F. Summersgill, et al., “Age, sexual behavior and human papillomavirus infection in oral cavity and oropharyngeal cancers,” International Journal of Cancer, vol. 108, no. 5, pp. 766–772, 2004.
- K. F. Summersgill, E. M. Smith, H. L. Kirchner, T. H. Haugen, and L. P. Turek, “p53 polymorphism, human papillomavirus infection in the oral cavity, and oral cancer,” Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics, vol. 90, no. 3, pp. 334–339, 2000.
- F. F. Chehab, M. Doherty, S. P. Cai, Y. W. Kan, S. Cooper, and E. M. Rubin, “Detection of sickle cell anaemia and thalassaemias,” Nature, vol. 329, no. 6137, pp. 293–294, 1987.
- Y. Ting and M. M. Manos, “Detection and typing of genital human papillomaviruses,” in PCR Protocols, A Guide to Methods and Applications, M. A. Innis, D. H. Gelfand, J. J. Sninsky, and T. J. White, Eds., pp. 356–367, Academic Press, Berkeley, Calif, USA, 1990.
- A. Hildesheim, M. H. Schiffman, P. E. Gravitt, et al., “Persistence of type-specific human papillomavirus infection among cytologically normal women,” Journal of Infectious Diseases, vol. 169, no. 2, pp. 235–240, 1994.
- A.-M. de Roda Husman, J. M. M. Walboomers, A. J. C. van den Brule, C. J. L. M. Meijer, and P. J. F. Snijders, “The use of general primers GP5 and GP6 elongated at their 3' ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR,” Journal of General Virology, vol. 76, no. 4, pp. 1057–1062, 1995.
- S. F. Altschul, T. L. Madden, A. A. Schäffer, et al., “Gapped BLAST and PSI-BLAST: a new generation of protein database search programs,” Nucleic Acids Research, vol. 25, no. 17, pp. 3389–3402, 1997.
- “SAS System for Windows,” version 9.1. Cary, NC, SAS Institute, 2002–2003.
- A. R. Kreimer, G. M. Clifford, P. Boyle, and S. Franceschi, “Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systemic review,” Cancer Epidemiology Biomarkers and Prevention, vol. 14, no. 2, pp. 467–475, 2005.
- J. G. Baseman and L. A. Koutsky, “The epidemiology of human papillomavirus infections,” Journal of Clinical Virology, vol. 32, supplement, pp. S16–S24, 2005.
- H. Richardson, G. Kelsall, P. Tellier, et al., “The natural history of type-specific human papillomavirus infections in female university students,” Cancer Epidemiology Biomarkers and Prevention, vol. 12, no. 6, pp. 485–490, 2003.
- A. R. Giuliano, R. Harris, R. L. Sedjo, et al., “Incidence, prevalence, and clearance of type-specific human papillomavirus infections: the Young Women's Health Study,” Journal of Infectious Diseases, vol. 186, no. 4, pp. 462–469, 2002.
- S. S. Wang, M. Schiffman, T. S. Shields, et al., “Seroprevalence of human papillomavirus16, 18, 31, and 45 in a population-based cohort of 10000 women in Costa Rica,” British Journal of Cancer, vol. 89, no. 7, pp. 1248–1254, 2003.
- B. Nonnenmacher, J. Pintos, M. C. Bozzetti, et al., “Epidemiologic correlates of antibody response to human papillomavirus among women at low risk of cervical cancer,” International Journal of STD & AIDS, vol. 14, no. 4, pp. 258–265, 2003.